Table 4.
Details of study subjects with negative outcomes in the three months following their discharge with a MUAC of 125 mm or greater (n = 5)
| Admission | Discharge | Follow-up | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Outcome | Sex | Age (months) | MUAC (mm)a | MUAC (mm) | WHZ | Length of stay (days) | Weight gain (%) | Duration of follow-upb (weeks) | Last known MUAC (mm)c | Illness during follow-up |
| Death | F | 9 | 112 | 125 | +0.30 | 56 | 10.0 | 10 | 134 | diarrhoea cough |
| Death | F | 14 | 110 | 128 | −0.01 | 105 | 14.7 | 6 | 120 | diarrhoea vomiting fever cough |
| Relapse | M | 14 | 110 | 126 | −0.08 | 84 | 26.8 | 12 | 110 | none recorded |
| Relapse | M | 12 | 104 | 130 | −0.39 | 35 | 26.8 | 8 | 114 | diarrhoea vomiting fever cough |
| Relapse | F | 9 | 110 | 128 | −0.65 | 112 | 30.0 | 6 | 115 | diarrhoea |
aNone of the children followed-up had oedema at admission
bThe follow-up visit prior to death or the follow-up visit when relapse was detected
cLast known MUAC for deaths is the MUAC recorded in the follow-up visit prior to death. Last known MUAC for relapsed cases is the MUAC at the follow-up visit at which relapse was detected. Relapsed cases were referred back to the therapeutic feeding program